Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
Giardia lamblia Dr Kamran Afzal Classified Microbiologist
INTRODUCTION Protozoan parasite Worldwide distribution Giardia lamblia  is a single-celled,  bi-nucleated intestinal parasite  Has trophozoite and cyst phases Lives in duodenum and jejunum Typically found in lakes, streams, or ponds that have been contaminated by human and other animals It causes giardiasis
MORPHOLOGY Two stages   Trophozoite Cyst Reproduction Binary fission
Trophozoite SHAPE Pear shaped Tear drop-shaped Tennis racket or heart shaped SIZE Length 10-20um Width 5-15um Thickness 2-5um
BODY Bilaterally symmetrical AXOSTYLES Two in numbers, seen in midline as vertical lines NUCLEI Two, one on each side of body
FLAGELLAE 8 flagellae  (2 anterior, 2 posterior, 2 ventral, and 2 caudal)  - all arise from kinetosome SUCKING DISCS 2, Circular in shape Situated on ventral surface
Cyst SHAPE Oval or ellipsoid SIZE Length 12um Width 8um NUCLEI Two nuclei in immature cyst Four nuclei in mature cyst FLAGELLAE AND SUCKING DISCS   May be seen in cytoplasm Mature cyst
LIFE CYCLE of  Giardia lamblia Trophozoites Trophozoites Cysts Mature Cysts Duodenum, upper ileum, gall bladder The lower portion of ileum or colon Contaminated water and food Stool Multiplied by  binary fission Diarrhea Outside Outside
 
HABITAT AND TRANSMISSION Trophozoites Colonizes in the intestines of mammals,  birds, reptiles and amphibians Definitive host is human intestine Duodenum and Jejunum Cyst Contaminated material Human colon Sigmoid colon TRANSMISSION Via fecal-oral route As few as 10 cysts can cause disease and up to 900 million cysts can be released by an infected individual in one day
Trophozoites are attached to the mucosal  surface by sucker,  reproduced by binary fission Diarrhea, abdominal pain, bloating,  nausea, and vomiting Mechanical blockage of the intestinal mucosa, competition for nutrients, inflammation Histology:  shortening of microvilli, elongation of crypts,  and damaging the brush border of the absorptive cells G. lamblia  inhabits the duodenum, jejunum and upper ileum PATHOGENESIS
PATHOGENESIS AND PATHOLOGY Fat/CHO digestion decreases and causes malabsorption and maldigestion  Absorption decreases due to villus blunting causing malabsorption Malabsorption and maldigestion causes diarrhea Physical damage: clubbing of villi; decreases villus-to-crypt ratio; brush borders of cells are irregular
Feeds on mucous that forms in response to irritation Also absorbs vitamins and amino acids Giardia can also interfere with vitamin/nutrient absorption Vitamin A   vision  Vitamin D   Rickets  Both of these are due to long standing infections
CLINICAL FEATURES Incubation  is 1- 2 weeks Onset  is gradual Symptoms  are nausea, vomiting, diarrhea, dehydration, malaise, flatulence, bloating, cramping, low grade fever and steatorrhea Sequelae  are malabsorption, lactase deficiency, weight loss, fatigue, depression and rarely reactive arthritis
DIAGNOSIS PATHOLOGICAL EXAMINATION Fecal examination Water-like feces Trophozoites Formed  feces Cysts Duodenal fluid or bile examination String test   Trophozoites
ELISA/ Rapid tests IFA PCR Histopathology
TREATMENT The most common treatment for giardiasis is  Metronidazole  (Flagyl) for 5-10 days It eradicates Giardia in more than 85% of cases Furazolidone  (Furoxone) for 7-10 days Quinacrine  is also very effective for treating giardiasis Combination therapy also may be effective Quinacrine and Metronidazole Tinidazole, Secnidazole and Albendazole
PREVENTION Avoid water and food that might be contaminated Boil water before drinking, even after filtration Do not brush teeth with tap water that may be contaminated Do not use ice or drink beverages made from tap water Wash hands before eating food
 
Entamoeba histolytica
INTRODUCTION Protozoan parasite Worldwide distribution Amoebic colitis and liver abscess
CLASSIFICATION Superclass  Rhizopoda Subphylum  Sarcodina Family  Entamoebidae Order  Amoebida Class  Labosea Species  Entamoeba
  SPECIES Entamoeba histolytica  Pathogenic Entamoeba dispar  Non pathogenic group E. hartmanni E. polecki E. coli E. gingivalis
MORPHOLOGY TROPHOZOITES Size 20-40 µm Nucleus Single (4-7 µm) Cytoplasm Ingested red cells Rich in glycogen Chromatoid bodies Locomotion Rapid, gliding, explosive with single pseudopodium
MORPHOLOGY CYSTS Shape  Spherical Size 10-16 µm Nuclei Four Glycogen vacuole Chromatoid bodies Killed by desiccation or boiling
EPIDEMIOLOGY Geographic distribution is worldwide Second to malaria as cause of death due to parasitic protozoa Transmission  is Fecal-Oral Hosts   are humans, cats, dogs and rats ~10%  world population infected Prevalence in tropical countries   is  >30%
10%  of infected persons develop  invasive disease 40,000-100,000  deaths  annually High prevalence  in low socio-economic status, overcrowding, poor personal hygiene, no indoor plumbing, immigrants from endemic areas, mentally retarded, promiscuous male homosexuals Increased severity  in children especially neonates, pregnancy and post-partum states, corticosteroid use, malignancy, malnutrition
LIFE CYCLE CYST Ingestion by humans Excystation in small intestine Encystation in colon Excretion in faeces TROPHOZOITE Asymptomatic colonization Amoebic colitis Liver abscess
 
VIRULENCE FACTORS GIAP Adherence Amebapore   Cytolytic Proteases   Necrosis Resistance to complement mediated lysis Trophozoites in liver abscess and  colonic lesions are resistant
PATHOGENESIS Invasive Mucosal necrosis Ulceration Dysentery Ulcer enlargement Colitis Peritonitis Amoeboma Metastasis  (Extra-intestinal disease) Dissemination via portal vein to liver Non-invasive Asymptomatic  colonization Non-dysenteric  diarrhea , cramps, abdominal discomfort
HOST IMMUNITY High titers of  anti-amoebic antibodies  occur by 7th day of illness Serum of patients with high titers of  anti-amoebic antibodies  causes lysis of trophozoites Recurrence  does not occur after liver abscess and colitis Amoebas  recovered from liver abscess and colonic lesions are resistant to complement mediated lesions
CLINICAL SYNDROMES INTESTINAL DISEASE Asymptomatic infection Symptomatic non-invasive infection Acute recto-colitis Fulminant colitis with perforation Toxic megacolon Amoeboma Perianal ulceration EXTRA-INTESTINAL DISEASE Liver abscess (via portal vein) Peritonitis Empyema Pericarditis Lung abscess Brain abscess Genito-urinary disease
Colitis is the most common form of disease associated with amoebae
Ulceration can lead to secondary infection and extraintestinal lesions
Extraintestinal amoebiasis
Amoebic liver abscess
LAB DIAGNOSIS Microscopy Culture Molecular Diagnosis Serology
MICROSCOPY Multiple samples are required Saline preparation  has very low yield Endoscopic biopsy/ulcer edge scrapings  has high yield  Stool  for hematophagous amoebas/Nuclear morphology Trichrome stain Iron Hematoxylin stain Concentration techniques  (Formal-acetate) Iodine staining for cysts
CULTURE Sensitive  but time consuming Multiple samples are not required NNN medium Does not differentiate  between  E. histolytica  and  E. dispar Helpful in  asymptomatic or chronic infections with low levels of cyst passage Useful to  evaluate efficacy of cure or existence of infection when the presence or absence of antibodies is not definitive
SEROLOGY Anti-amoebic Antibodies (IgG and IgM) Develop only in  E. histolytica  infections High levels occur in 80% acute cases and 90%  convalescent cases Titers remain high for years, not useful in endemic areas ELISA stool antigen Rapid and simple High sensitivity and specificity Can distinguish between  E. histolytica  and  E. dispar ELISA serum antigen IHA   Useful in liver abscess and colitis
MOLECULAR DIAGNOSIS PCR High sensitivity and specificity Can also detect trophozoites by detecting rRNA genes
HISTOPATHOLOGY
TREATMENT E. dispar  carriage  does not require treatment Asymptomatic  E. histolytica  carriage  should be treated Intraluminal Infection Diloxanide furoate 500mg TDS for 10 days Paromomycin  Iodoquinol Symptomatic Amoebiasis Metronidazole 750mg TDS for 5-10 days Tinidazole, Secnidazole and Albendazole
Extra-intestinal Amoebiasis Metronidazole + Paromomycin/Diloxanide furoate   +  Emetine Needle Aspiration For large abscess Open Surgical Drainage If needle aspiration is not possible Perforation/Peritonitis Anti-protozoal drugs + Antibacterial drugs + Peritoneal drainage
PREVENTION Adequate water purification Low levels of chlorine does not kill cysts Boiling  of drinking water Treating vegetables  and fruits with strong detergent soap and then soaking in acetic acid for 5-10 minutes Proper  waste disposal Immunization Under trial

More Related Content

Giardia+Entamoeba

  • 1. Giardia lamblia Dr Kamran Afzal Classified Microbiologist
  • 2. INTRODUCTION Protozoan parasite Worldwide distribution Giardia lamblia is a single-celled, bi-nucleated intestinal parasite Has trophozoite and cyst phases Lives in duodenum and jejunum Typically found in lakes, streams, or ponds that have been contaminated by human and other animals It causes giardiasis
  • 3. MORPHOLOGY Two stages Trophozoite Cyst Reproduction Binary fission
  • 4. Trophozoite SHAPE Pear shaped Tear drop-shaped Tennis racket or heart shaped SIZE Length 10-20um Width 5-15um Thickness 2-5um
  • 5. BODY Bilaterally symmetrical AXOSTYLES Two in numbers, seen in midline as vertical lines NUCLEI Two, one on each side of body
  • 6. FLAGELLAE 8 flagellae (2 anterior, 2 posterior, 2 ventral, and 2 caudal) - all arise from kinetosome SUCKING DISCS 2, Circular in shape Situated on ventral surface
  • 7. Cyst SHAPE Oval or ellipsoid SIZE Length 12um Width 8um NUCLEI Two nuclei in immature cyst Four nuclei in mature cyst FLAGELLAE AND SUCKING DISCS May be seen in cytoplasm Mature cyst
  • 8. LIFE CYCLE of Giardia lamblia Trophozoites Trophozoites Cysts Mature Cysts Duodenum, upper ileum, gall bladder The lower portion of ileum or colon Contaminated water and food Stool Multiplied by binary fission Diarrhea Outside Outside
  • 9.  
  • 10. HABITAT AND TRANSMISSION Trophozoites Colonizes in the intestines of mammals, birds, reptiles and amphibians Definitive host is human intestine Duodenum and Jejunum Cyst Contaminated material Human colon Sigmoid colon TRANSMISSION Via fecal-oral route As few as 10 cysts can cause disease and up to 900 million cysts can be released by an infected individual in one day
  • 11. Trophozoites are attached to the mucosal surface by sucker, reproduced by binary fission Diarrhea, abdominal pain, bloating, nausea, and vomiting Mechanical blockage of the intestinal mucosa, competition for nutrients, inflammation Histology: shortening of microvilli, elongation of crypts, and damaging the brush border of the absorptive cells G. lamblia inhabits the duodenum, jejunum and upper ileum PATHOGENESIS
  • 12. PATHOGENESIS AND PATHOLOGY Fat/CHO digestion decreases and causes malabsorption and maldigestion Absorption decreases due to villus blunting causing malabsorption Malabsorption and maldigestion causes diarrhea Physical damage: clubbing of villi; decreases villus-to-crypt ratio; brush borders of cells are irregular
  • 13. Feeds on mucous that forms in response to irritation Also absorbs vitamins and amino acids Giardia can also interfere with vitamin/nutrient absorption Vitamin A  vision Vitamin D  Rickets Both of these are due to long standing infections
  • 14. CLINICAL FEATURES Incubation is 1- 2 weeks Onset is gradual Symptoms are nausea, vomiting, diarrhea, dehydration, malaise, flatulence, bloating, cramping, low grade fever and steatorrhea Sequelae are malabsorption, lactase deficiency, weight loss, fatigue, depression and rarely reactive arthritis
  • 15. DIAGNOSIS PATHOLOGICAL EXAMINATION Fecal examination Water-like feces Trophozoites Formed feces Cysts Duodenal fluid or bile examination String test Trophozoites
  • 16. ELISA/ Rapid tests IFA PCR Histopathology
  • 17. TREATMENT The most common treatment for giardiasis is Metronidazole (Flagyl) for 5-10 days It eradicates Giardia in more than 85% of cases Furazolidone (Furoxone) for 7-10 days Quinacrine is also very effective for treating giardiasis Combination therapy also may be effective Quinacrine and Metronidazole Tinidazole, Secnidazole and Albendazole
  • 18. PREVENTION Avoid water and food that might be contaminated Boil water before drinking, even after filtration Do not brush teeth with tap water that may be contaminated Do not use ice or drink beverages made from tap water Wash hands before eating food
  • 19.  
  • 21. INTRODUCTION Protozoan parasite Worldwide distribution Amoebic colitis and liver abscess
  • 22. CLASSIFICATION Superclass Rhizopoda Subphylum Sarcodina Family Entamoebidae Order Amoebida Class Labosea Species Entamoeba
  • 23. SPECIES Entamoeba histolytica Pathogenic Entamoeba dispar Non pathogenic group E. hartmanni E. polecki E. coli E. gingivalis
  • 24. MORPHOLOGY TROPHOZOITES Size 20-40 µm Nucleus Single (4-7 µm) Cytoplasm Ingested red cells Rich in glycogen Chromatoid bodies Locomotion Rapid, gliding, explosive with single pseudopodium
  • 25. MORPHOLOGY CYSTS Shape Spherical Size 10-16 µm Nuclei Four Glycogen vacuole Chromatoid bodies Killed by desiccation or boiling
  • 26. EPIDEMIOLOGY Geographic distribution is worldwide Second to malaria as cause of death due to parasitic protozoa Transmission is Fecal-Oral Hosts are humans, cats, dogs and rats ~10% world population infected Prevalence in tropical countries is >30%
  • 27. 10% of infected persons develop invasive disease 40,000-100,000 deaths annually High prevalence in low socio-economic status, overcrowding, poor personal hygiene, no indoor plumbing, immigrants from endemic areas, mentally retarded, promiscuous male homosexuals Increased severity in children especially neonates, pregnancy and post-partum states, corticosteroid use, malignancy, malnutrition
  • 28. LIFE CYCLE CYST Ingestion by humans Excystation in small intestine Encystation in colon Excretion in faeces TROPHOZOITE Asymptomatic colonization Amoebic colitis Liver abscess
  • 29.  
  • 30. VIRULENCE FACTORS GIAP Adherence Amebapore Cytolytic Proteases Necrosis Resistance to complement mediated lysis Trophozoites in liver abscess and colonic lesions are resistant
  • 31. PATHOGENESIS Invasive Mucosal necrosis Ulceration Dysentery Ulcer enlargement Colitis Peritonitis Amoeboma Metastasis (Extra-intestinal disease) Dissemination via portal vein to liver Non-invasive Asymptomatic colonization Non-dysenteric diarrhea , cramps, abdominal discomfort
  • 32. HOST IMMUNITY High titers of anti-amoebic antibodies occur by 7th day of illness Serum of patients with high titers of anti-amoebic antibodies causes lysis of trophozoites Recurrence does not occur after liver abscess and colitis Amoebas recovered from liver abscess and colonic lesions are resistant to complement mediated lesions
  • 33. CLINICAL SYNDROMES INTESTINAL DISEASE Asymptomatic infection Symptomatic non-invasive infection Acute recto-colitis Fulminant colitis with perforation Toxic megacolon Amoeboma Perianal ulceration EXTRA-INTESTINAL DISEASE Liver abscess (via portal vein) Peritonitis Empyema Pericarditis Lung abscess Brain abscess Genito-urinary disease
  • 34. Colitis is the most common form of disease associated with amoebae
  • 35. Ulceration can lead to secondary infection and extraintestinal lesions
  • 38. LAB DIAGNOSIS Microscopy Culture Molecular Diagnosis Serology
  • 39. MICROSCOPY Multiple samples are required Saline preparation has very low yield Endoscopic biopsy/ulcer edge scrapings has high yield Stool for hematophagous amoebas/Nuclear morphology Trichrome stain Iron Hematoxylin stain Concentration techniques (Formal-acetate) Iodine staining for cysts
  • 40. CULTURE Sensitive but time consuming Multiple samples are not required NNN medium Does not differentiate between E. histolytica and E. dispar Helpful in asymptomatic or chronic infections with low levels of cyst passage Useful to evaluate efficacy of cure or existence of infection when the presence or absence of antibodies is not definitive
  • 41. SEROLOGY Anti-amoebic Antibodies (IgG and IgM) Develop only in E. histolytica infections High levels occur in 80% acute cases and 90% convalescent cases Titers remain high for years, not useful in endemic areas ELISA stool antigen Rapid and simple High sensitivity and specificity Can distinguish between E. histolytica and E. dispar ELISA serum antigen IHA Useful in liver abscess and colitis
  • 42. MOLECULAR DIAGNOSIS PCR High sensitivity and specificity Can also detect trophozoites by detecting rRNA genes
  • 44. TREATMENT E. dispar carriage does not require treatment Asymptomatic E. histolytica carriage should be treated Intraluminal Infection Diloxanide furoate 500mg TDS for 10 days Paromomycin Iodoquinol Symptomatic Amoebiasis Metronidazole 750mg TDS for 5-10 days Tinidazole, Secnidazole and Albendazole
  • 45. Extra-intestinal Amoebiasis Metronidazole + Paromomycin/Diloxanide furoate + Emetine Needle Aspiration For large abscess Open Surgical Drainage If needle aspiration is not possible Perforation/Peritonitis Anti-protozoal drugs + Antibacterial drugs + Peritoneal drainage
  • 46. PREVENTION Adequate water purification Low levels of chlorine does not kill cysts Boiling of drinking water Treating vegetables and fruits with strong detergent soap and then soaking in acetic acid for 5-10 minutes Proper waste disposal Immunization Under trial

Editor's Notes

  1. ss